| Identification | Back Directory | [Name]
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-octyl-, (6aR,10aR)- | [CAS]
431041-39-3 | [Synonyms]
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-octyl-, (6aR,10aR)- | [Molecular Formula]
C24H36O2 | [MOL File]
431041-39-3.mol | [Molecular Weight]
356.54 |
| Hazard Information | Back Directory | [Description]
Δ8-THC-C8 (exempt preparation) is an analytical reference standard categorized as a synthetic cannabinoid.1 Δ8-THC-C8 induces hypothermia, hypomotility, and antinociception in mice. Δ8-THC-C8 is regulated as a Schedule I compound in the United States. Δ8-THC-C8 (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | [Uses]
Δ8-THC-C8 is a semi-synthetic cannabinoid. Δ8-THC-C8 is a cannabinoid receptor 1 (CB1) activator with an EC50 of 13.8 nM[1]. | [IC 50]
CB1: 13.8 nM (EC50) | [References]
1. Martin, B.R., Jefferson, R., Winckler, R., et al. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists J. Pharmacol. Exp. Ther. 290(3),1065-1079(1999). |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|